rs16992990

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_033409.4(SLC52A3):​c.600C>T​(p.Pro200Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00855 in 1,598,728 control chromosomes in the GnomAD database, including 378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 46 hom., cov: 32)
Exomes 𝑓: 0.0083 ( 332 hom. )

Consequence

SLC52A3
NM_033409.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.68

Publications

2 publications found
Variant links:
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
SLC52A3 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • progressive bulbar palsy
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 20-763971-G-A is Benign according to our data. Variant chr20-763971-G-A is described in ClinVar as Benign. ClinVar VariationId is 262236.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.68 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.065 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033409.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
NM_033409.4
MANE Select
c.600C>Tp.Pro200Pro
synonymous
Exon 3 of 5NP_212134.3
SLC52A3
NM_001370085.1
c.600C>Tp.Pro200Pro
synonymous
Exon 4 of 6NP_001357014.1
SLC52A3
NM_001370086.1
c.600C>Tp.Pro200Pro
synonymous
Exon 4 of 6NP_001357015.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
ENST00000645534.1
MANE Select
c.600C>Tp.Pro200Pro
synonymous
Exon 3 of 5ENSP00000494193.1
SLC52A3
ENST00000217254.11
TSL:5
c.600C>Tp.Pro200Pro
synonymous
Exon 4 of 6ENSP00000217254.7
SLC52A3
ENST00000488495.3
TSL:3
c.600C>Tp.Pro200Pro
synonymous
Exon 3 of 5ENSP00000494009.1

Frequencies

GnomAD3 genomes
AF:
0.0104
AC:
1576
AN:
151746
Hom.:
45
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00335
Gnomad ASJ
AF:
0.0363
Gnomad EAS
AF:
0.0432
Gnomad SAS
AF:
0.0707
Gnomad FIN
AF:
0.00170
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00202
Gnomad OTH
AF:
0.0106
GnomAD2 exomes
AF:
0.0174
AC:
3805
AN:
218302
AF XY:
0.0203
show subpopulations
Gnomad AFR exome
AF:
0.0172
Gnomad AMR exome
AF:
0.00317
Gnomad ASJ exome
AF:
0.0360
Gnomad EAS exome
AF:
0.0437
Gnomad FIN exome
AF:
0.000876
Gnomad NFE exome
AF:
0.00306
Gnomad OTH exome
AF:
0.0114
GnomAD4 exome
AF:
0.00835
AC:
12079
AN:
1446864
Hom.:
332
Cov.:
61
AF XY:
0.0101
AC XY:
7283
AN XY:
718584
show subpopulations
African (AFR)
AF:
0.0183
AC:
607
AN:
33136
American (AMR)
AF:
0.00300
AC:
124
AN:
41362
Ashkenazi Jewish (ASJ)
AF:
0.0354
AC:
914
AN:
25844
East Asian (EAS)
AF:
0.0344
AC:
1340
AN:
38920
South Asian (SAS)
AF:
0.0683
AC:
5771
AN:
84474
European-Finnish (FIN)
AF:
0.000950
AC:
50
AN:
52646
Middle Eastern (MID)
AF:
0.0223
AC:
127
AN:
5694
European-Non Finnish (NFE)
AF:
0.00207
AC:
2287
AN:
1104906
Other (OTH)
AF:
0.0143
AC:
859
AN:
59882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
822
1644
2465
3287
4109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0104
AC:
1583
AN:
151864
Hom.:
46
Cov.:
32
AF XY:
0.0118
AC XY:
879
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.0160
AC:
662
AN:
41394
American (AMR)
AF:
0.00335
AC:
51
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.0363
AC:
126
AN:
3468
East Asian (EAS)
AF:
0.0425
AC:
218
AN:
5130
South Asian (SAS)
AF:
0.0712
AC:
341
AN:
4788
European-Finnish (FIN)
AF:
0.00170
AC:
18
AN:
10588
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00202
AC:
137
AN:
67938
Other (OTH)
AF:
0.0123
AC:
26
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
77
153
230
306
383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00510
Hom.:
7
Bravo
AF:
0.00998
Asia WGS
AF:
0.0570
AC:
197
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 23, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Pro200Pro in exon 3 of SLC52A3: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 8.23% (1024/12440) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://ex ac.broadinstitute.org; dbSNP rs16992990).

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Aug 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Progressive bulbar palsy of childhood;C0796274:Brown-Vialetto-van Laere syndrome 1 Benign:1
Jul 30, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Brown-Vialetto-van Laere syndrome 1 Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.29
DANN
Benign
0.35
PhyloP100
-2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16992990; hg19: chr20-744615; COSMIC: COSV105094371; API